Cardiovascular Preventing Effects of Dipeptidyl Peptidase-4 Inhibitors: Beyond Glucagon-Like Peptide-1

被引：0
|
作者：
Wang, Xi-Mei
Yang, Yue-Jin
Wu, Yong-Jian
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 110卷 / 10期
关键词：
INFARCTION;
D O I：
10.1016/j.amjcard.2012.08.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1551 / 1551
页数：1
相关论文
共 50 条
  • [1] Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist
    Kershaw V. Patel
    Ashish Sarraju
    Ian J. Neeland
    Darren K. McGuire
    Current Cardiology Reports, 2020, 22
  • [2] Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist
    Patel, Kershaw, V
    Sarraju, Ashish
    Neeland, Ian J.
    McGuire, Darren K.
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (10)
  • [3] Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
    Nauck, Michael A.
    Meier, Juris J.
    Cavender, Matthew A.
    Abd El Aziz, Mirna
    Drucker, Daniel J.
    CIRCULATION, 2017, 136 (09) : 849 - U176
  • [4] Diuretic and Natriuretic Effects of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin: The Contribution of Glucagon-like Peptide-1
    Moroi, Masao
    Kubota, Tetsuya
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 66 (02) : 159 - 164
  • [5] Utilization of Glucagon-Like Peptide-1 Receptor Agonist and Dipeptidyl Peptidase-4 Inhibitors at the Veterans Health Administration
    Krishnan, Aditya
    Suryanarayanan, Sowmya K.
    Mansi, Ishak A.
    JOURNAL OF PHARMACY TECHNOLOGY, 2024, 40 (05) : 223 - 229
  • [6] Effects of dipeptidyl peptidase-4 inhibitors in a type 2 diabetes patient with failure of glucagon-like peptide-1 receptor agonists
    Wang, Yufan
    Zhao, Li
    Huang, Qianfang
    Peng, Yongde
    JOURNAL OF DIABETES, 2014, 6 (02) : 164 - 166
  • [7] Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes
    Senyigit, Abdulhalim
    Tabak, Omur
    Orbanoglu, Timur
    Karadag, Aytac
    Ugurlu, Serdal
    Uzun, Hafize
    Konukoglu, Dihlar
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (05): : E188 - E199
  • [8] Dipeptidyl peptidase-4 (DPP-4) inhibitors are favourable to Glucagon-Like Peptide-1 (GLP-1) agonists: No
    Madsbad, Sten
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (02) : 132 - 136
  • [9] Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease
    Tan, Xi
    Liang, Yuanjie
    Rajpura, Jigar R.
    Yedigarova, Larisa
    Noone, Josh
    Xie, Lin
    Inzucchi, Silvio
    de Havenon, Adam
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [10] Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease
    Xi Tan
    Yuanjie Liang
    Jigar R. Rajpura
    Larisa Yedigarova
    Josh Noone
    Lin Xie
    Silvio Inzucchi
    Adam de Havenon
    Cardiovascular Diabetology, 22
12345